Skip to content

Making it Work Program for Systemic Sclerosis

Evaluation of the Making it Work Program for Systemic Sclerosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06338722
Enrollment
33
Registered
2024-04-01
Start date
2023-12-08
Completion date
2025-01-22
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scleroderma, Systemic

Keywords

work

Brief summary

The purpose of this clinical trial is to see if an online intervention program for people with Systemic Sclerosis (scleroderma) helps keep people in the workforce and increase self-confidence in dealing with challenges at work. The program is called Making it Work Systemic Sclerosis. Researchers will compare a group who gets the program to a group who will get the program at a later point in time (wait list control group) to see if self-confidence in dealing with work challenge gets better. People in the Making it Work group will complete questionnaires and attend one 2 hour meetings each week for 5 weeks and meet with an occupational therapist and vocational counselor. People in the wait list control group will complete the questionnaires and participate in the program at a later point in time.

Interventions

OTHERMaking it Work Systemic Sclerosis

One 2 hour virtual meeting per week for 5 weeks, plus an individual meeting with an occupational therapist and a vocational counselor

Sponsors

University of New Mexico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

People will know what group they are in when they are invited to attend the intervention sessions

Intervention model description

Intervention receives the Making it work program Wait list Control receives usual care but will be offered the program after the intervention groups finish

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
No

Inclusion criteria

* Currently employed (full-time, part-time) * Over 18 and less than or equal to 67 years of age * Reside and work in the United States * Self-report diagnosis with systemic sclerosis (scleroderma; systemic sclerosis) * Report concerns about risk for job loss * Possess sufficient spoken English to participate in a group * Have device with audio and visual videoconferencing capabilities * Be willing to participate in a 2.0 hour virtual meeting once a week for 5 weeks * Be willing to complete assigned pre-meeting worksheets * Be willing to meet virtually with both an occupational therapist and vocational counselor after the 5th weekly sessin.

Exclusion criteria

* Not working (full-time, part-time, self-employed, contract work) * Pregnant * Less than 18 and over 67 years of age * Do not work in the United States * Do not report are not concerned about job loss * Do not have a device with audio and visual videoconferencing capabilities * Do note communicate sufficiently in English * Are not able to participate in the program for 5 weeks * Are not wiling to complete pre-meeting worksheets * Not willing to meet with both an occupational therapist and vocational counselor.

Design outcomes

Primary

MeasureTime frameDescription
Job Related Self-efficacy Scalebaseline, 5 weeks, 12 weeks, 24 weeksMeasures self-efficacy for managing problems/challenges at work
Job Self-Efficacy Scalebaseline, 5 weeks, 12 weeks, 24 weeksMeasures confidence in concepts targeted by the Making it Work Program such as disease management at work, stress management, ability to communicate effectively, obtaining job accommodations

Secondary

MeasureTime frameDescription
Work Productivity and Activity Impairment Questionnaire Specific Health Problem Subscalebaseline, 5 weeks, 12 weeks, 24 weeksMeasures absenteeism \[secondary outcome; hours and days missed from work due to SSc\] and presenteeism \[secondary outcome; at-work productivity\].
The Work Instability Scalebaseline, 5 weeks, 12 weeks, 24 weeksMeasures risk for future work loss

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026